|
DNA typing methods used to free the wrongly incarcerated and
identify victims of mass disasters will be highlighted at this year's
17th International Symposium on Human Identification starting October
9 in Nashville, Tennessee. Featured topics at this year's symposium
include: the release of Christopher Ochoa who served over 12 years
in jail as an innocent man, as well as the use of DNA typing in
mass disasters such as Katrina and the Thai Tsunami.
"DNA analysts constantly face new circumstances and new challenges
for human identity testing. The public's new acquaintance with DNA
typing through the mass media convinces some that DNA results can
be conjured practically out of thin air", says Promega Corporation
CEO Bill Linton. "We know this is not true, but fortunately, the
pace of technology is allowing DNA analysts to solve more difficult
and complex cases than ever. Upcoming advances may soon allow DNA
analysts to keep up with the public's growing expectations."
The four day symposium, sponsored by Promega Corporation, covers
a breadth of information that focuses on the forensic science field.
This year, speakers discuss new techniques in DNA typing including
familial searching as a method to identify suspects, DNA identification
of the putative Mozart Skull as well as "Interesting Cases" featuring
DNA analysts describing their toughest and most unusual cases.
The Symposium, just for DNA analysts, is the largest such event
in the world. This year it takes place October 9-12 at the Gaylord
Opryland Resort in Nashville, Tennessee. Please visit
www.promega.com/geneticsymp17 for more
information.
About Promega
Promega Corporation is a leader in providing innovative solutions
and technical support to the life sciences industry. The company's
products enable scientists worldwide to advance their knowledge
in human identification, genomics, proteomics, cellular analysis,
and molecular diagnostics. Founded in 1978, the company is headquartered
in Madison, WI, USA with branches in twelve countries and 54 global
distributors. Annual sales exceed $175 million.
|
